Columbia, SC

Spica Clinical Research

Meningococcal Infections

Colorectal Cancer

Exact Sciences Corporation

Sanofi

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

The purpose of VAN00010 study is to assess the safety and immunogenicity of the investigational pentavalent meningococcal ABCYW vaccine in adults and adolescents.

The study duration will be up to 12 months for all participants.

Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents

Spica Clinical Research | Columbia, SC

Site insights

Work at this site?

Active trials

Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents

Trial sponsors